308 related articles for article (PubMed ID: 32229073)
1. The addition of interstitial needles to intracavitary applicators in the treatment of locally advanced cervical cancer: Why is this important and how to implement in low- and middle-income countries?
Lombe D; Crook J; Bachand F; Moore J; Hamm J; Rose T; Anderson D; Batchelar D
Brachytherapy; 2020; 19(3):316-322. PubMed ID: 32229073
[TBL] [Abstract][Full Text] [Related]
2. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy.
Schnell E; Thompson S; Ahmad S; Herman TS; De La Fuente Herman T
Med Dosim; 2020 Spring; 45(1):21-27. PubMed ID: 31101569
[TBL] [Abstract][Full Text] [Related]
4. New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame.
Trnková P; Pötter R; Baltas D; Karabis A; Fidarova E; Dimopoulos J; Georg D; Kirisits C
Radiother Oncol; 2009 Nov; 93(2):331-40. PubMed ID: 19846230
[TBL] [Abstract][Full Text] [Related]
5. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
6. Deformable image registration-based contour propagation yields clinically acceptable plans for MRI-based cervical cancer brachytherapy planning.
Chapman CH; Polan D; Vineberg K; Jolly S; Maturen KE; Brock KK; Prisciandaro JI
Brachytherapy; 2018; 17(2):360-367. PubMed ID: 29331573
[TBL] [Abstract][Full Text] [Related]
7. Who Really Benefits from 3D-Based Planning of Brachytherapy for Cervical Cancer?
Ha IB; Jeong BK; Kang KM; Jeong H; Lee YH; Choi HS; Lee JH; Choi WJ; Shin JK; Song JH
J Korean Med Sci; 2018 Apr; 33(18):e135. PubMed ID: 29713255
[TBL] [Abstract][Full Text] [Related]
8. Direction Modulated Brachytherapy for Treatment of Cervical Cancer. II: Comparative Planning Study With Intracavitary and Intracavitary-Interstitial Techniques.
Han DY; Safigholi H; Soliman A; Ravi A; Leung E; Scanderbeg DJ; Liu Z; Owrangi A; Song WY
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):440-448. PubMed ID: 27598809
[TBL] [Abstract][Full Text] [Related]
9. [Dosimetric evaluation of intracavitary-interstitial image-guided adaptive brachytherapy of cervical cancer and comparison with conventional treatment techniques].
Fröhlich G; Vízkeleti J; Nhung NA; Horváth K; Major T; Polgár C
Magy Onkol; 2018 Dec; 62(4):242-248. PubMed ID: 30540867
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
[TBL] [Abstract][Full Text] [Related]
11. 3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
Fredman E; Traughber B; Podder T; Colussi V; Zheng Y; Russo S; Herrmann K; Paspulati R; Waggoner S; Zanotti K; Nagel C; Nakayama J; Machtay M; Ellis R
Brachytherapy; 2018; 17(2):334-344. PubMed ID: 29097137
[TBL] [Abstract][Full Text] [Related]
12. Characterization of combined intracavitary/interstitial brachytherapy including oblique needles in locally advanced cervix cancer.
Serban M; Fokdal L; Nielsen SK; Hokland SB; Hansen AT; Spejlborg H; Rylander S; Petric P; Lindegaard JC; Tanderup K
Brachytherapy; 2021; 20(4):796-806. PubMed ID: 33994344
[TBL] [Abstract][Full Text] [Related]
13. Investigation of whether in-room CT-based adaptive intracavitary brachytherapy for uterine cervical cancer is robust against interfractional location variations of organs and/or applicators.
Oku Y; Arimura H; Nguyen TT; Hiraki Y; Toyota M; Saigo Y; Yoshiura T; Hirata H
J Radiat Res; 2016 Nov; 57(6):677-683. PubMed ID: 27296250
[TBL] [Abstract][Full Text] [Related]
14. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
Kirisits C; Lang S; Dimopoulos J; Berger D; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):624-30. PubMed ID: 16690444
[TBL] [Abstract][Full Text] [Related]
15. Predicting which patients may benefit from the hybrid intracavitary+interstitial needle (IC/IS) applicator for advanced cervical cancer: A dosimetric comparison and toxicity benefit analysis.
Gonzalez Y; Giap F; Klages P; Owrangi A; Jia X; Albuquerque K
Brachytherapy; 2021; 20(1):136-145. PubMed ID: 33132073
[TBL] [Abstract][Full Text] [Related]
16. Clinical feasibility of interstitial brachytherapy using a "hybrid" applicator combining uterine tandem and interstitial metal needles based on CT for locally advanced cervical cancer.
Liu ZS; Guo J; Lin X; Wang HY; Qiu L; Ren XJ; Li YF; Zhang BY; Wang TJ
Brachytherapy; 2016; 15(5):562-9. PubMed ID: 27474180
[TBL] [Abstract][Full Text] [Related]
17. A novel two-step optimization method for tandem and ovoid high-dose-rate brachytherapy treatment for locally advanced cervical cancer.
Sharma M; Fields EC; Todor DA
Brachytherapy; 2015; 14(5):613-8. PubMed ID: 26092424
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer.
Sarwar KA; Hussain S; Syed AS; Khan K; Maqsood T; Azeem T
Brachytherapy; 2024; 23(1):10-17. PubMed ID: 37813708
[TBL] [Abstract][Full Text] [Related]
19. Practically achievable maximum high-risk clinical target volume doses in MRI-guided intracavitary brachytherapy for cervical cancer: a planning study.
Menon G; Huang F; Sloboda R; Pearcey R; Ghosh S
Brachytherapy; 2014; 13(6):572-8. PubMed ID: 25085455
[TBL] [Abstract][Full Text] [Related]
20. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.
Nomden CN; de Leeuw AA; Van Limbergen E; de Brabandere M; Nulens A; Nout RA; Laman M; Ketelaars M; Lutgens L; Reniers B; Jürgenliemk-Schulz IM
Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
